A phase 1 study of a novel inhibitor of protein phosphatase 2A alone and with docetaxel.
Year: 2014
Type: conference-abstract
Source: Journal of Clinical Oncology
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4252732887
